MAPT and Alzheimer disease: Increased cholesterol levels have been associated with cognitive decline and AD development via various pathways and mechanisms like Aβ accumulation, dysfunction of the BBB, oxidative stress, vascular compromise, neuroinflammation, tau hyperphosphorylation and brain parenchyma structural changes [144].